Igm Biosciences Inc (IGMS)

Nov 15, 2024

Will Imvotamab Data Propel IGM Biosciences To New Heights In 2025? - RTTNews

Nov 15, 2024

Nov 13, 2024

IGM Biosciences' SWOT analysis: stock pivot to autoimmune focus sparks analyst optimism - Investing.com

Nov 13, 2024

Nov 13, 2024

How To Trade (IGMS) - Stock Traders Daily

Nov 13, 2024

Nov 13, 2024

FMR LLC Increases Stake in IGM Biosciences Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

IGM Biosciences Insiders Who Sold Avert US$165m Market Cap Dip - Simply Wall St

Nov 12, 2024

Nov 11, 2024

Biotech firm backs off its focus on oncology research - The Business Journals

Nov 11, 2024

Nov 11, 2024

IGM Biosciences (NASDAQ:IGMS) Given New $27.00 Price Target at Stifel Nicolaus - MarketBeat

Nov 11, 2024

Nov 11, 2024

Igm Biosciences: Navigating Financial Challenges Amidst Early-Stage Antibody Development - MSN

Nov 11, 2024

Nov 10, 2024

IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 10, 2024

Nov 09, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Down 7.8%Here's Why - MarketBeat

Nov 09, 2024

Nov 08, 2024

IGM Biosciences Inc (IGMS) Quarterly 10-Q Report - Quartz

Nov 08, 2024

Nov 08, 2024

IGM Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024

Nov 08, 2024

IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

IGM Biosciences earnings missed by $0.21, revenue topped estimates - Investing.com UK

Nov 08, 2024

Nov 08, 2024

IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 08, 2024

Nov 08, 2024

IGM Biosciences Reports $61.4M Loss, Extends Cash Runway to 2027 Despite Clinical Progress | IGMS Stock News - StockTitan

Nov 08, 2024

Nov 07, 2024

IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 07, 2024

Nov 04, 2024

IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewswire

Nov 04, 2024

Nov 02, 2024

(IGMS) Investment Report - Stock Traders Daily

Nov 02, 2024

Nov 01, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Down 3.7%Should You Sell? - MarketBeat

Nov 01, 2024

Oct 29, 2024

Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) PT at $15.00 - Defense World

Oct 29, 2024

Oct 28, 2024

IGM Biosciences (NASDAQ:IGMS) Trading 7.7% HigherHere's Why - MarketBeat

Oct 28, 2024

Oct 26, 2024

IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Oct 26, 2024

Oct 25, 2024

IGM Biosciences' SWOT analysis: autoimmune pivot drives stock outlook - Investing.com India

Oct 25, 2024

Oct 24, 2024

IGM Biosciences' SWOT analysis: autoimmune pivot drives stock outlook By Investing.com - Investing.com South Africa

Oct 24, 2024

Oct 22, 2024

Exchange Traded Concepts LLC Trims Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World

Oct 22, 2024

Oct 21, 2024

IGM Biosciences’ stock tumbles as analysts weigh in on pivot plan with dismay - MSN

Oct 21, 2024

Oct 21, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Down 6.1%Here's What Happened - MarketBeat

Oct 21, 2024

Oct 20, 2024

IGM Biosciences (NASDAQ:IGMS) PT Raised to $20.00 at Royal Bank of Canada - Defense World

Oct 20, 2024

Oct 19, 2024

AQR Capital Management LLC Acquires Shares of 12,230 IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World

Oct 19, 2024

Oct 18, 2024

IGM Biosciences (NASDAQ:IGMS) PT Raised to $20.00 - MarketBeat

Oct 18, 2024

Oct 17, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Up 8%Here's What Happened - MarketBeat

Oct 17, 2024

Oct 15, 2024

IGM Biosciences, Inc. (NASDAQ:IGMS) Short Interest Down 23.9% in September - MarketBeat

Oct 15, 2024

Oct 15, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Down 5.5%Time to Sell? - MarketBeat

Oct 15, 2024

Oct 15, 2024

Dimensional Fund Advisors LP Lowers Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World

Oct 15, 2024

Oct 11, 2024

IGM Biosciences (NASDAQ:IGMS) Trading Up 8.1%Here's What Happened - MarketBeat

Oct 11, 2024

Oct 09, 2024

Marshall Wace LLP Has $737,000 Stock Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat

Oct 09, 2024

Oct 05, 2024

IGM Biosciences (NASDAQ:IGMS) Trading 10.1% Higher – Here’s What Happened - Defense World

Oct 05, 2024

Oct 04, 2024

IGM Biosciences (NASDAQ:IGMS) Trading Up 10.1%Time to Buy? - MarketBeat

Oct 04, 2024

Oct 03, 2024

IGM Biosciences Shifts Focus to Autoimmunity, Appoints New CEO - TipRanks

Oct 03, 2024

Oct 03, 2024

IGM Biosciences downgraded to Hold, stock falls - MSN

Oct 03, 2024

Oct 03, 2024

Wedbush Comments on IGM Biosciences, Inc.'s Q3 2024 Earnings (NASDAQ:IGMS) - MarketBeat

Oct 03, 2024

Oct 03, 2024

Wedbush Comments on IGM Biosciences, Inc.’s Q3 2024 Earnings (NASDAQ:IGMS) - Defense World

Oct 03, 2024

Oct 02, 2024

The Attractiveness of Investing In IGM Biosciences Inc (IGMS) is Growing - Knox Daily

Oct 02, 2024

Oct 02, 2024

IGM Biosciences (NASDAQ:IGMS) Trading Down 7.4% Following Analyst Downgrade - MarketBeat

Oct 02, 2024

Oct 02, 2024

Balance Sheet Insights: IGM Biosciences Inc (IGMS)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 02, 2024

Oct 02, 2024

Guggenheim Trims IGM Biosciences (NASDAQ:IGMS) Target Price to $20.00 - Defense World

Oct 02, 2024

Oct 02, 2024

IGM Biosciences, Inc. (NASDAQ:IGMS) Expected to Earn Q2 2025 Earnings of ($0.38) Per Share - MarketBeat

Oct 02, 2024